x
x
x
x

Wed, June 02, 2021

WADA publishes Stakeholder Notices relating to meat and diuretics contamination cases

WADA publishes Stakeholder Notices relating to meat and diuretics contamination cases

The World Anti-Doping Agency has published Stakeholder Notices that were developed by the Contaminants Working Group to provide guidance for potential meat and diuretic contamination cases.

On 20 May 2021 the Executive Committee unanimously approved recommendations from the Contaminants Working Group regarding Minimum Reporting Levels for growth promoters and diuretics. The recommendations were made in order to assist the anti-doping community with dealing with contamination cases, particularly in relation to meat and diuretics.

The Stakeholder Notice in relation to meat contamination says that “For cases of clenbuterol, ractopamine, zilpaterol or zeranol or its metabolite(s) at a concentration at or below 5 ng/mL, WADA-accredited laboratories shall report the result as an Atypical Finding, and the Results Management Authority shall conduct an investigation, to determine whether that finding may be due to ingestion of contaminated meat.” The Notice continued to say that following the investigation a case may be closed if it is determined that the substance detected was consistent with meat contamination, if it is determined that the finding was not caused by meat contamination then the case will be pursued.

The Stakeholder Notice regarding potential diuretic contamination reads “For cases of acetazolamide, bumetanide, furosemide, hydrochlorothiazide, torasemide and triamterene, the presence of one or more of these diuretics or their metabolite(s) in an athlete’s urine sample at an estimated concentration at or below 20 ng/mL will not be reported as an Adverse Analytical Finding or as an Atypical Finding.” The Notice continues “However, where a sample is collected from an athlete participating in a sport or discipline that uses weight classes, WADA-accredited Laboratories shall report the presence of one or more of these six diuretics or their metabolite(s) at an estimated concentration equal to or below the Minimum Reporting Level of 20 ng/mL as an Atypical Finding.”

You can read the WADA statement here.

Share

Recent News Articles

Tue, June 06, 2023

Concussion in grassroots and school sport to be monitored by UK government

The UK government is to conduct research into concussion in grassroots sport, using an app to track the symptoms of injury and their treatment 

Read More

Mon, June 05, 2023

WADA issues Anti-Doping Rule Violations Report for 2020

The World Anti-Doping Agency (WADA) has published the Anti-Doping Rule Violations (ADRVs) Report for 2020. 

Read More

Fri, June 02, 2023

More than two dozen Canadian sporting organisations call on Trudeau to launch a national inquiry

More than two dozen Canadian sporting organisations and activist groups have called on Prime Minister Justin Trudeau to launch a national inquiry into the toxic culture of abuse in sport in the country. 

Read More